1. Home
  2. SW vs ROIV Comparison

SW vs ROIV Comparison

Compare SW & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smurfit WestRock plc Ordinary Shares

SW

Smurfit WestRock plc Ordinary Shares

N/A

Current Price

$48.56

Market Cap

22.6B

Sector

N/A

ML Signal

N/A

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

N/A

Current Price

$35.01

Market Cap

23.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SW
ROIV
Founded
1934
2014
Country
Ireland
United Kingdom
Employees
97000
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.6B
23.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SW
ROIV
Price
$48.56
$35.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
9
Target Price
$53.58
$28.94
AVG Volume (30 Days)
4.2M
5.0M
Earning Date
04-30-2026
05-28-2026
Dividend Yield
4.56%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$8,260,000.00
Revenue This Year
$4.43
N/A
Revenue Next Year
$3.13
$744.61
P/E Ratio
$38.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.73
$10.90
52 Week High
$52.65
$37.00

Technical Indicators

Market Signals
Indicator
SW
ROIV
Relative Strength Index (RSI) 62.60 57.78
Support Level $40.75 $33.56
Resistance Level $47.86 $37.00
Average True Range (ATR) 1.77 1.11
MACD 0.09 -0.24
Stochastic Oscillator 99.10 41.02

Price Performance

Historical Comparison
SW
ROIV

About SW Smurfit WestRock plc Ordinary Shares

Smurfit WestRock PLC manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. operates a vertically integrated system supplying wood and recovered fiber to produce various grades of board, which are then converted into packaging products. Its main packaging categories include corrugated containers and consumer packaging, with additional products such as solidboard, kraft paper, graphic board, paper sacks, and bag-in-box packaging. The company's geographical segments include North America (including the U.S., Canada and Mexico), Europe, the Middle East and Africa and Asia-Pacific, and Latin America. The majority of the company's revenue is derived from product sales in the North American region.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: